China Shineway Pharmaceutical Group Limited 每股年股息为 0.4932,收益率为 0.00%。股息每 每季度 支付,最近的除息日为 Sep 9, 2025。
股息收益率
年度股息
除息日
0.00%
$0.4932
Sep 9, 2025
支付频率
派息比率
每季度
0.00%
股息历史
除息日
现金金额
记录日期
付款日期
Sep 9, 2025
$0.12
Sep 10, 2025
Sep 26, 2025
Apr 30, 2025
$0.385
May 2, 2025
May 20, 2025
Sep 10, 2024
$0.12
Sep 11, 2024
Sep 27, 2024
Apr 29, 2024
$0.461
Apr 30, 2024
May 17, 2024
Apr 29, 2024
$0.461
Apr 30, 2024
May 17, 2024
Sep 12, 2023
$0.118
Sep 13, 2023
Sep 29, 2023
股息图表
CSWYF 股息
CSWYF 股息增长率(同比)
Follow-Up Questions
China Shineway Pharmaceutical Group Limited 当前的股息支付和年度股息是多少?
China Shineway Pharmaceutical Group Limited 的股息支付比率是多少?
CSWYF 的除息日是什么?
China Shineway Pharmaceutical Group Limited 多久支付一次股息?
关键数据
前收盘价
$1
开盘价
$1
当日区间
$0.9253 - $1
52周范围
$0.9253 - $1
交易量
100
平均成交量
0
每股收益(TTM)
0.21
股息收益率
--
市值
$758.4M
什么是 CHINA SHINEWAY PHARMACEUTICAL G?
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 2,867 full-time employees. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.